Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2025-12-28 @ 8:21 PM
Study NCT ID:
NCT06643793
Status:
RECRUITING
Last Update Posted:
2025-01-28
First Post:
2024-09-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC
Sponsor:
Affiliated Hospital of Nantong University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-11-04
Start Date Type:
ACTUAL
Primary Completion Date:
2026-10-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-09-27
First Submit QC Date:
None
Study First Post Date:
2024-10-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-26
Last Update Post Date:
2025-01-28
Last Update Post Date Type:
ACTUAL